Skip to content
Application 209822
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | VIGABATRIN | VIGABATRIN | TABLET;ORAL | 500MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0591-3851 | Vigabatrin | Vigabatrin | Actavis Pharma, Inc. | ANDA | Current |
| 0591-3851 | Vigabatrin | Vigabatrin | Actavis Pharma, Inc. | ANDA | Current |
| 0591-3851 | Vigabatrin | Vigabatrin | Actavis Pharma, Inc. | ANDA | Current |
| 0591-3851 | Vigabatrin | Vigabatrin | Actavis Pharma, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 76528 | ORIG | 2023-11-08 |
| 65833 | ORIG | 2021-01-06 |
| 57720 | ORIG | 2019-02-21 |